Skip to content
Recall Observatory FDA recall evidence

Drug product

Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield, NJ 07004 NDC 69315-904-05

D-0085-2018

September 28, 2017

Class II

Product summary

Firm
Leading Pharma, LLC
Event
Event 78471
Status
Terminated
Classification
Class II
Quantity
2952 500-count bottles
Official record key
drug-enforcement:D-0085-2018

Official wording

Reason: Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam

Code information: Lot #E00717

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling: Label Error